Skip to main content

Menarini Silicon Biosystems to Distribute Healgen Coronavirus Tests in the US

NEW YORK ─ Menarini Silicon Biosystems said on Wednesday that it has signed a non-exclusive distribution agreement to sell a rapid antibody detection kit in the US manufactured by Houston, Texas-based Healgen Scientific.

Financial and other terms of the agreement were not disclosed.

Healgen's COVID-19 IgG/IgM Rapid Test Cassette, which detects immunoglobulin G (IgG) and immunoglobulin M (IgM) antibodies in 10 minutes, can help clinicians determine whether a person has been previously infected with SARS-CoV-2, Menarini Silicon said. 

The test received Emergency Use Authorization from the US Food & Drug Administration Emergency Use Authorization in May. It is available in Europe through A. Menarini Diagnostics, the European diagnostics division of the multinational Menarini Group.

Bologna, Italy-based Menarini Silicon Biosystems is a subsidiary of the Menarini Group, and Healgen Scientific is a subsidiary of China-based Zhejiang Orient Gene Biotech.